PetVivo Animal Health Expands Veterinary Education with New RACE-Approved CE Courses on Osteoarthritis and Regenerative Therapies
PetVivo Animal Health (OTCQX: PETV) has launched three new RACE-approved continuing education (CE) courses for veterinary professionals, each offering 1.0 credit hour. The courses focus on osteoarthritis (OA) management and regenerative therapies for both small animal and equine practices.
The educational program includes three distinct courses: an introductory course on OA care in small animals, an advanced course on joint injections, and a specialized course on regenerative therapies in equine practice. These courses combine scientific research with practical instruction and are available at no cost to veterinary professionals through PetVivo's online learning platform.
PetVivo Animal Health (OTCQX: PETV) ha lanciato tre nuovi corsi di formazione continua (CE) approvati da RACE per i professionisti veterinari, ciascuno valido per 1 ora di credito. I corsi si concentrano sulla gestione dell'osteoartrite (OA) e sulle terapie rigenerative sia per le pratiche di piccoli animali sia per quelle equine.
Il programma educativo comprende tre corsi distinti: un corso introduttivo sulla cura dell'OA nei piccoli animali, un corso avanzato sulle iniezioni articolari e un corso specializzato sulle terapie rigenerative nell'ambito della pratica equina. Questi corsi combinano ricerca scientifica con istruzioni pratiche e sono disponibili gratuitamente per i professionisti veterinari tramite la piattaforma di apprendimento online di PetVivo.
PetVivo Animal Health (OTCQX: PETV) ha lanzado tres nuevos cursos de educación continua (CE) aprobados por RACE para profesionales veterinarios, cada uno con 1 hora de crédito. Los cursos se enfocan en el manejo de la osteoartritis (OA) y en terapias regenerativas para prácticas de pequeños animales y de equinos.
El programa educativo incluye tres cursos distintos: uno introductorio sobre el cuidado de OA en animales pequeños, otro avanzado sobre inyecciones articulares y un curso especializado sobre terapias regenerativas en la práctica equina. Estos cursos combinan investigación científica con instrucción práctica y están disponibles de forma gratuita para profesionales veterinarios a través de la plataforma de aprendizaje en línea de PetVivo.
PetVivo Animal Health (OTCQX: PETV)가 RACE 인증 CE 과정 3개를 새로 개설했다. 각 과정은 1.0 학점이며, 소동물 및 말 진료에서의 골관절염(OA 관리)과 재생 치료에 초점을 맞춘다.
교육 프로그램은 소동물 OA 관리 기초 과정, 관절 주사 심화 과정, 말 진료의 재생 치료 특화 과정의 세 가지 과정을 포함한다. 이 과정은 과학 연구와 실습 지침을 결합하며 PetVivo의 온라인 학습 플랫폼을 통해 수의 전문직 종사자에게 무료로 제공된다.
PetVivo Animal Health (OTCQX: PETV) a lancé trois nouveaux cours de formation continue (CE) approuvés par RACE pour les professionnels vétérinaires, chacun offrant 1 heure de crédit. Les cours portent sur la gestion de l’arthrose (OA) et les thérapies régénératives pour les pratiques des petits animaux et des équins.
Le programme éducatif comprend trois cours distincts : un cours d’introduction sur les soins de l’OA chez les petits animaux, un cours avancé sur les injections articulaires et un cours spécialisé sur les thérapies régénératives en pratique équine. Ces cours allient recherche scientifique et enseignement pratique et sont disponibles gratuitement pour les professionnels vétérinaires via la plateforme d’apprentissage en ligne de PetVivo.
PetVivo Animal Health (OTCQX: PETV) hat drei neue von RACE anerkannte Weiterbildungskurse (CE) für Tierärzte gestartet, von denen jeder 1,0 Kreditstunde umfasst. Die Kurse konzentrieren sich auf das Management der Osteoarthritis (OA) und regenerative Therapien sowohl für Kleintierpraxen als auch für Pferdepraxen.
Das Bildungsprogramm umfasst drei unterschiedliche Kurse: Einen Einführungskurs zur OA-Pflege bei Kleintieren, einen fortgeschrittenen Kurs zu Gelenkinjektionen und einen spezialisierten Kurs zu regenerativen Therapien in der Pferdepraxis. Diese Kurse verbinden wissenschaftliche Forschung mit praktischer Anleitung und stehen Tierärzten über die Online-Lernplattform von PetVivo kostenfrei zur Verfügung.
PetVivo Animal Health (OTCQX: PETV) أطلقت ثلاث دورات جديدة في التعليم المستمر (CE) معتمدة من RACE للطبيبين البيطريين، كل دورة تمنح ساعة اعتماد واحدة. تركز الدورات على إدارة التهاب المفاصل العظمي OA والتقنيات العلاجية التجديدية في عيادات الحيوانات الصغيرة والخيول.
يشمل البرنامج التعليمي ثلاث دورات مميزة: دورة تمهيدية عن رعاية OA لدى الحيوانات الصغيرة، ودورة متقدمة حول حقن المفاصل، ودورة متخصصة في العلاجات التجديدية في ممارسة الخيول. تجمع هذه الدورات بين البحث العلمي والتعليم العملي وهي متاحة مجاناً للمتخصصين البيطريين عبر منصة PetVivo التعليمية على الإنترنت.
PetVivo Animal Health (OTCQX: PETV) 已为兽医专业人员推出三门新的由 RACE 批准的继续教育课程（CE），每门课程提供 1 学时学分。课程聚焦于骨关节炎（OA）的管理以及小动物和马匹诊疗中的再生治疗。
教育项目包括三门不同的课程：一门关于小动物 OA 护理的入门课程，一门关于关节注射的高级课程，以及一门关于马匹诊疗中再生治疗的专门课程。这些课程将科学研究与实践教学相结合，且对兽医专业人员通过 PetVivo 的在线学习平台免费开放。
- Free access to RACE-approved CE courses for veterinary professionals
- Expansion of educational resources in regenerative medicine and OA management
- Strategic positioning of company's Spryng product within educational content
- None.
On-demand programs deliver clinically relevant science, technical instruction, and case applications in small animal and equine practice
MINNEAPOLIS, Sept. 25, 2025 (GLOBE NEWSWIRE) -- PetVivo Animal Health, a subsidiary of PetVivo Holdings, Inc. (OTCQX: PETV; OTCID: PETVW) and a veterinary medical device company pioneering intra-articular and regenerative solutions, announces the launch of three new continuing education (CE) courses for veterinary professionals. Each RACE-approved program (1.0 credit hour) is designed to help veterinarians deepen their expertise in osteoarthritis (OA), joint injection techniques, and regenerative modalities for canine and equine patients.
The courses - developed and delivered by practicing veterinarians with expertise in surgery and rehabilitation - combine current research with practical, case-driven instruction to bridge the gap between emerging science and everyday practice.
Course offerings include:
- Advancing Care for Osteoarthritis in Small Animal Practice (Introductory)
Provides an updated overview of OA pathophysiology and the degenerative cascade leading to progressive disease. Reviews multimodal management strategies, with emphasis on the role of intra-articular injections as part of proactive OA care. - Opening the OA Toolbox: Diving Deeper into Joint Injections (Advanced, Small Animal)
Explores the biomechanics of joint instability and its contribution to arthritic change. Covers current treatment modalities, available intra-articular products, and step-by-step instruction for performing joint injections. Discusses proactive vs. reactive use of injections to improve long-term outcomes. - Regenerative Therapies in Equine Practice: Optimizing Outcomes in OA Management
Examines equine OA pathophysiology and key drivers of degenerative joint disease in athletic horses. Reviews the scientific rationale and evidence base for regenerative modalities - including platelet-rich plasma (PRP), mesenchymal stem cells, and biomaterial-based devices such as Spryng® - and discusses integration into multimodal treatment protocols.
“These programs were designed to deliver both a strong scientific foundation and hands-on clinical perspective,” said April Boyce, Vice President of Sales and Marketing at PetVivo Animal Health. “By combining pathophysiology, therapeutic mechanisms, and case applications, veterinary professionals gain tools to evaluate candidates for regenerative options and implement protocols that move beyond symptomatic relief toward supporting joint health at the source.”
PetVivo Animal Health’s CE initiative reflects a broader commitment to advancing regenerative medicine in veterinary practice. By emphasizing mechanisms of action, disease-modifying potential, and clinical application, these courses aim to prepare practitioners for the growing role of regenerative modalities in OA management.
The courses are open at no cost to veterinarians, veterinary technicians, and allied professionals.
To enroll, visit https://petvivoanimalhealth.thinkific.com/.
About PetVivo Animal Health
PetVivo Animal Health, Inc., a wholly-owned subsidiary of PetVivo Holdings, Inc. (OTCQX: PETV; OTCID: PETVW), is a veterinary medical device and regenerative therapies company dedicated to improving the lives of animals through innovative solutions for the management of osteoarthritis and other joint-related conditions. The company’s portfolio includes Spryng® with OsteoCushion® Technology, an intra-articular injectable veterinary medical device designed to provide long-term joint support, and PrecisePRP™, a convenient, shelf-stable platelet-rich plasma (PRP) product. By focusing on regenerative medicine and intra-articular therapies, PetVivo delivers cutting-edge options that help veterinary professionals support mobility, comfort, and quality of life in their patients.
For more information, visit www.petvivoanimalhealth.com
CONTACT:
April Boyce
Vice President of Sales and Marketing
PetVivo Holdings, Inc.
Email: aboyce@petvivo.com
(952) 405-6216
Forward-Looking Statements:
The foregoing material may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, each as amended. Forward-looking statements include all statements that do not relate solely to historical or current facts, including without limitation the Company’s proposed development and commercial timelines, and can be identified by the use of words such as “may,” “will,” “expect,” “project,” “estimate,” “anticipate,” “plan,” “believe,” “potential,” “should,” “continue” or the negative versions of those words or other comparable words. Forward-looking statements are not guarantees of future actions or performance. These forward-looking statements are based on information currently available to the Company and its current plans or expectations and are subject to a number of uncertainties and risks that could significantly affect current plans. Risks concerning the Company’s business are described in detail in the Company’s Annual Report on Form 10-K for the year ended March 31, 2025, and other periodic and current reports filed with the Securities and Exchange Commission. The Company is under no obligation to, and expressly disclaims any such obligation to, update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.
FAQ
What new CE courses has PetVivo (PETV) launched for veterinary professionals?
Are PetVivo's (PETV) new veterinary CE courses free?
What topics do PetVivo's (PETV) new CE courses cover?
Where can veterinary professionals access PetVivo's (PETV) new CE courses?
